Colchicine in the treatment of AA and AL amyloidosis (Q40709737)

23 September 2017

1 reference

title

Colchicine in the treatment of AA and AL amyloidosis (English)

1 reference

23 September 2017

1 reference

3

Langevitz P

1 reference

23 September 2017

4

Shemer J

1 reference

23 September 2017

Livneh A

1

1 reference

23 September 2017

Zemer D

series ordinal

2

1 reference

23 September 2017

Sohar E

series ordinal

5

1 reference

23 September 2017

Pras M

series ordinal

6

1 reference

23 September 2017

1 December 1993

1 reference

Seminars in Arthritis and Rheumatism

23 September 2017

1 reference

23 September 2017

23

1 reference

23 September 2017

3

1 reference

23 September 2017

206-214

1 reference

Chemical and clinical classification of amyloidosis 1985.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

1 reference

7 January 2021

Clinical-pathologic differentiation of common amyloid syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

A clinical analysis of the course and prognosis of forty-two patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Familial Mediterranean fever. A survey of 470 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

The Amino Acid Sequence of a Major Nonimmunoglobulin Component of Some Amyloid Fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Amyloidosis in familial Mediterranean fever. An independent genetically determined character

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine for familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

A controlled trial of colchicine in preventing attacks of familial mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine therapy for familial mediterranean fever. A double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Prolonged colchicine treatment in four patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Familial Mediterranean fever and amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Familial Mediterranean fever in the colchicine era: the fate of one family

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Reversal of the Nephrotic Syndrome by Colchicine in Amyloidosis of Familial Mediterranean Fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Letter: Remission in renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Is amyloid A (AA) amyloidosis always secondary?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

AA protein in a case of "primary" or "idiopathic" amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Systemic Amyloidosis in Behçet's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Amyloidosis in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Remission of the Nephrotic Syndrome in Renal Amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Resolution of renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Regression of amyloid in Crohn's disease after bowel resection. A 19-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Resolution of secondary amyloidosis 14 years after adequate chemotherapy for skeletal tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Spontaneous remissions of nephrotic syndrome in renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

The expanding spectrum of a disease. Behçet's disease associated with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Crohn's ileitis complicated by amyloidosis: observations and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine therapy of the renal amyloidosis of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine and secondary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Correlation of clinical, biochemical and functional parameters with histological lesions in secondary renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Treatment of AL amyloidosis with melphalan, prednisone, and colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Bullous hemorrhagic primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine in systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

DMSO and colchicine therapy in amyloid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Serum amyloid A protein in familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Long-term colchicine treatment in children with familial mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Azoospermia caused by colchicine--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Colchicine myopathy and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Therapy of Primary Amyloidosis With Melphalan and Prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

Resolution of amyloidosis (AA type) complicating chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980042-3

7 January 2021

10.1016/S0049-0172(05)80042-3

Identifiers

DOI

1 reference

23 September 2017

1 reference